Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection
Value Health
.
2014 Nov;17(7):A637.
doi: 10.1016/j.jval.2014.08.2288.
Epub 2014 Oct 26.
Authors
F Gervais
1
,
Y Jiang
1
,
N Largeron
2
,
T Nikoglou
2
Affiliations
1
Amaris, London, UK.
2
Sanofi Pasteur MSD, Lyon, France.
PMID:
27202273
DOI:
10.1016/j.jval.2014.08.2288
No abstract available